# Author Information

## To Be Completed

This file contains placeholder information for author details to be finalized before submission.

---

## Author List

### Template

**[Author 1 Name]**^1,*^
- Affiliation: [Institution, Department, City, Country]
- ORCID: [XXXX-XXXX-XXXX-XXXX]
- Email: [email@institution.edu]
- Role: [Conceptualization, Methodology, Software, Validation, Writing - Original Draft]

**[Author 2 Name]**^1,2^
- Affiliation 1: [Institution, Department, City, Country]
- Affiliation 2: [Institution, Department, City, Country]
- ORCID: [XXXX-XXXX-XXXX-XXXX]
- Email: [email@institution.edu]
- Role: [Methodology, Validation, Writing - Review & Editing]

*Corresponding author

---

## Affiliations

1. [Primary Institution, Department, Address]
2. [Secondary Institution, Department, Address]

---

## Author Contributions

Using CRediT (Contributor Roles Taxonomy):

| Author | Conceptualization | Methodology | Software | Validation | Formal Analysis | Investigation | Data Curation | Writing - Original | Writing - Review | Visualization | Supervision | Project Admin | Funding |
|--------|-------------------|-------------|----------|------------|-----------------|---------------|---------------|-------------------|------------------|---------------|-------------|---------------|---------|
| [Author 1] | X | X | X | X | X | X | X | X | X | X | | | |
| [Author 2] | | X | | X | | | | | X | | | | |

---

## Corresponding Author

**Name**: [To be determined]
**Address**: [Full postal address]
**Email**: [Email address]
**Phone**: [Phone number]
**ORCID**: [ORCID ID]

---

## Competing Interests Statement

The authors declare no competing financial interests.

*Alternative (if applicable)*:
[Author Name] has received consulting fees from [Company]. [Author Name] holds equity in [Company]. The remaining authors declare no competing interests.

---

## Funding Statement

This work was supported by [Funding Agency] grant [Grant Number] to [PI Name].

*Or*:
The authors received no specific funding for this work.

---

## Acknowledgements

We thank [Names] for helpful discussions and feedback on earlier versions of this manuscript.

We acknowledge the expert reviewers who participated in the parameter elicitation process (listed in Supplementary Materials).

---

## Data and Code Availability

**Data Availability**: All data used in this study are derived from published literature and publicly available sources. Validation case data and sources are documented in Supplementary Table S3.

**Code Availability**: The AI Research Acceleration Model v1.1 is implemented in Python and available at [GitHub repository URL / Zenodo DOI]. The repository includes:
- `ai_acceleration_model.py` - Core model implementation
- `enhanced_features.py` - Policy ROI, bottleneck analysis, and supplementary modules
- `visualizations.py` - Figure generation code
- All supplementary tables in markdown format

---

## Keywords

- Artificial intelligence
- Biological research
- Drug discovery
- Technology forecasting
- Research acceleration
- Science policy

---

## Subject Categories

Primary: Computational biology and bioinformatics
Secondary: Drug discovery, Science policy

---

## Checklist Before Submission

- [ ] All authors have reviewed and approved the final manuscript
- [ ] All authors have agreed to the author order
- [ ] Corresponding author contact information is complete
- [ ] All affiliations are accurate and current
- [ ] ORCID IDs collected for all authors
- [ ] Competing interests declared (or declared none)
- [ ] Funding sources acknowledged
- [ ] Data/code availability statement finalized
- [ ] Repository created and DOI assigned (Zenodo)

---

*Last updated: [Date]*
